Investment
Features
FeesSafety
Academy
More
Pluang+

Compare DoorDash Inc (DASH) vs Sana Biotechnology Inc (SANA) Price & Performance

DoorDash IncTrade
Sana Biotechnology IncTrade

Price performance (Past 24H)

Key statistics

DoorDash Inc vs Sana Biotechnology Inc — how do they compare? DoorDash Inc trades at $212.03 (market cap $91.86B), while Sana Biotechnology Inc trades at $3.78 (market cap $1.13B). The key difference: DoorDash Inc is far larger — about 81.3× Sana Biotechnology Inc's market cap, and DoorDash Inc is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals.

DASHSANA
Market Cap
$91.86B$1.13B
Sector
Consumer CyclicalHealth
52-Week High
$281.74$5.92
52-Week Low
$146.60$2.68
Enterprise Value
$89.82B$1.05B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

DoorDash Inc

DoorDash (DASH) trades at $209.86, down 2.96% today, amid mixed earnings results but strong revenue growth. The stock shows a bullish technical trend above key support levels, with a 75.68% analyst buy rating. Recent Q2 2026 revenue beat expectations, though EPS missed due to higher R&D costs, while the company projects robust Q3 growth and continues investing in AI and autonomous delivery.

Outlook remains positive driven by expanding market share and profitability, but risks include intense competition and cost pressures. The consensus price target of $247.41 suggests ~18% upside, supported by solid cash flow and strategic acquisitions, though valuation multiples are elevated.

Sana Biotechnology Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About DoorDash Inc

Founded in 2013 and headquartered in San Francisco, DoorDash is an online food order demand aggregator. Consumers can use its app to order food on-demand for pickup or delivery from merchants mainly in the U.S. The firm provides a marketplace for the merchants to create a presence online, market their offerings, and meet demand by making the offerings available for pickup or delivery. The firm provides similar service to businesses in addition to restaurants, such as grocery, retail, pet supplies, and flowers. At the end of 2020, DoorDash had over 450,000 merchants, 20 million consumers, and over 1 million dashers on its platform. In 2020, the firm generated $24.7 billion in gross order volume (up 207% year over year) and $2.9 billion in revenue (up 226%).

Read more on DASH

About Sana Biotechnology Inc

Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.

Read more on SANA